FDA
approval
· 2022-06-15
FDA Approved: EXEMESTANE — Supplemental Application (Breckenridge Pharmaceutical, Inc.)
Summary
FDA approved a supplemental application for Exemestane from Breckenridge Pharmaceutical, Inc. The approval pertains to the generic product under the ANDA pathwa…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for EXEMESTANE (EXEMESTANE)